Ballenger Jc

812 total citations
19 papers, 650 citations indexed

About

Ballenger Jc is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ballenger Jc has authored 19 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Psychiatry and Mental health, 5 papers in Experimental and Cognitive Psychology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ballenger Jc's work include Bipolar Disorder and Treatment (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Ballenger Jc is often cited by papers focused on Bipolar Disorder and Treatment (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Ballenger Jc collaborates with scholars based in United States. Ballenger Jc's co-authors include Post Rm, Post Rm, Goodwin Fk, Karl Rickels, Charles H. Kellner, van Kammen Dp, Walter Lovenberg, Pauline Lerner, Kopin Ij and Scott W. Woods and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Ballenger Jc

18 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ballenger Jc United States	15	327	135	129	128	109	19	650
Kelly Schwartz United States	8	324 1.0×	89 0.7×	158 1.2×	124 1.0×	172 1.6×	8	674
M.Dhyanne Warner United States	14	296 0.9×	90 0.7×	82 0.6×	64 0.5×	84 0.8×	34	741
Stanley R. Platman United States	16	487 1.5×	67 0.5×	89 0.7×	135 1.1×	144 1.3×	44	915
B. Woggon Switzerland	11	274 0.8×	123 0.9×	40 0.3×	88 0.7×	172 1.6×	62	599
L. Branchey United States	18	133 0.4×	123 0.9×	106 0.8×	165 1.3×	79 0.7×	25	821
P. J. Perry United States	12	526 1.6×	97 0.7×	66 0.5×	138 1.1×	216 2.0×	20	872
Gary M. Levin United States	15	399 1.2×	54 0.4×	118 0.9×	124 1.0×	153 1.4×	33	794
W Pöldinger Switzerland	14	248 0.8×	117 0.9×	35 0.3×	180 1.4×	134 1.2×	76	753
Burton J. Goldstein United States	14	233 0.7×	176 1.3×	47 0.4×	198 1.5×	242 2.2×	47	755
T. A. Ban United States	15	276 0.8×	66 0.5×	53 0.4×	128 1.0×	155 1.4×	73	709

Countries citing papers authored by Ballenger Jc

Since Specialization

Citations

This map shows the geographic impact of Ballenger Jc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ballenger Jc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ballenger Jc more than expected).

Fields of papers citing papers by Ballenger Jc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ballenger Jc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ballenger Jc. The network helps show where Ballenger Jc may publish in the future.

Co-authorship network of co-authors of Ballenger Jc

This figure shows the co-authorship network connecting the top 25 collaborators of Ballenger Jc. A scholar is included among the top collaborators of Ballenger Jc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ballenger Jc. Ballenger Jc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jc, Ballenger, et al.. (1997). A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.. PubMed. 58 Suppl 11. 11–8. 22 indexed citations

Jc, Ballenger. (1997). Discussion and overview: what can we learn if we view panic disorder across the life span and across different presentations and contexts?. PubMed. 61(2 Suppl A). A95–102. 1 indexed citations

Jc, Ballenger, et al.. (1992). Tricyclic antidepressant triggers mania in patient with organic affective disorder.. PubMed. 53(10). 377–8. 2 indexed citations

Jc, Ballenger, Susan A. McDonald, R. Dirk Noyes, et al.. (1991). The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder.. PubMed. 27(2). 171–47. 33 indexed citations

Kellner, Charles H., et al.. (1989). Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.. PubMed. 25(1). 68–70. 44 indexed citations

Jc, Ballenger, et al.. (1989). Naproxen reversal of nortriptyline-induced orthostatic hypotension.. PubMed. 50(9). 356–356. 3 indexed citations

Jc, Ballenger. (1988). The clinical use of carbamazepine in affective disorders.. PubMed. 49 Suppl. 13–21. 36 indexed citations

Jc, Ballenger. (1988). The use of anticonvulsants in manic-depressive illness.. PubMed. 49 Suppl. 21–5. 14 indexed citations

Jc, Ballenger, et al.. (1986). Can panic disorder present as irritable bowel syndrome?. PubMed. 47(9). 470–3. 66 indexed citations

10.

Jc, Ballenger. (1986). Pharmacotherapy of the panic disorders.. PubMed. 47 Suppl. 27–32. 69 indexed citations

11.

Jc, Ballenger & Post Rm. (1984). Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses.. PubMed. 20(3). 572–84. 34 indexed citations

12.

Rm, Post, et al.. (1984). The efficacy of carbamazepine in affective illness.. PubMed. 39. 421–37. 14 indexed citations

13.

Rm, Post, et al.. (1983). Cerebrospinal fluid somatostatin in primary affective disorder.. PubMed. 19(3). 422–5. 8 indexed citations

14.

Jc, Ballenger, et al.. (1983). Neurohypophyseal function in affective illness.. PubMed. 19(3). 426–31. 16 indexed citations

15.

Rm, Post, et al.. (1982). Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness.. PubMed. 17(9). 1037–45. 16 indexed citations

16.

Fk, Goodwin, et al.. (1981). Cerebrospinal fluid amine metabolites and cyclic nucleotides in human aggression [proceedings].. PubMed. 17(1). 63–5. 39 indexed citations

17.

Jc, Ballenger, et al.. (1981). Plasma and CSF MHPG in normals [proceedings].. PubMed. 17(1). 86–7. 43 indexed citations

18.

Lerner, Pauline, Goodwin Fk, van Kammen Dp, et al.. (1978). Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 13(6). 685–94. 47 indexed citations

19.

Jc, Ballenger & Post Rm. (1978). Therapeutic effects of carbamazepine in affective illness: a preliminary report.. PubMed. 2(2). 159–75. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact